Exemestane

Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression

Items (National)
174.7K
NHS Cost
£1.4M
Practices
5,377
Avg per Practice
33

Overview

Exemestane is prescribed by 5,377 GP practices across England. In the last 12 months, 174,717 items were prescribed at a total cost of £1,393,661 to the NHS. It is classified under BNF Chapter Malignant Disease and Immunosuppression, Section Sex hormones and hormone antagonists in malignant disease.

Monthly Prescribing Trend

Jun 2026
7,842
Jun 2026
7,290
Jun 2026
8,061
Jun 2026
7,881
Jun 2026
7,685
Jun 2026
8,281
Jun 2026
7,925
Jun 2026
8,083
Jun 2026
8,164
Jun 2026
7,340
Jun 2026
7,632
Jun 2026
7,577

Prescribing by Area

AreaItemsPracticesAvg/Practicevs National
S 5,585 132 42 +30.2% ▲
B 5,169 152 34 +4.6% ▲
BS 5,021 76 66 +103.4% ▲
NE 4,985 103 48 +48.9% ▲
GL 4,509 61 74 +127.4% ▲
PE 3,879 82 47 +45.5% ▲
NR 3,738 67 56 +71.7% ▲
TN 3,631 65 56 +72.0% ▲
EX 3,338 57 59 +80.3% ▲
L 3,266 103 32 -2.5% ▼
PL 3,245 47 69 +112.3% ▲
ME 3,242 60 54 +66.2% ▲
PR 2,951 61 48 +48.9% ▲
YO 2,902 42 69 +112.6% ▲
NG 2,821 81 35 +7.1% ▲
CV 2,813 78 36 +11.1% ▲
E 2,786 87 32 -1.5% vs avg
DN 2,707 66 41 +26.2% ▲
LS 2,632 64 41 +26.5% ▲
M 2,529 87 29 -10.5% ▼
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.